Aprameya Engineering Q2 Results 2026 (FY27) statement: Revenue & Margins
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
Guidance rank: #13 of 13 in Healthcare Equipment & Supplies
See the sector's top 10 — free with your mobile number.
Aprameya Engineering Ltd Q2 FY27 key numbers
- Revenue
- Other income stands at Rs. 101.12 lakhs (Consolidated).
As stated in Aprameya Engineering Ltd's Q2 FY27 results statement · published 15 Nov 2026. Reported figures, not investment advice.
Based on Aprameya Engineering Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
Revenue from operations for the half year ended 30.09.2026 is Rs. 1,712.53 lakhs (Consolidated) and Rs. 1,673.57 lakhs (Standalone). EBITDA for the quarter: Rs. 216.21 lakhs, up 97% year-on-year (YoY).
From Aprameya Engineering Ltd's Q2 FY27 earnings-call transcript · updated 15 Nov 2026.
How did Aprameya Engineering's revenue grow in the September 2026 quarter?
- Revenue from operations for the half year ended 30.09.2026 is Rs. 1,712.53 lakhs (Consolidated) and Rs. 1,673.57 lakhs (Standalone).
- Year-on-year revenue comparison for the same period: Consolidated revenue increased from Rs. 421.398 lakhs (30.09.2025) to Rs. 1,712.53 lakhs, indicating strong growth.
- Other income stands at Rs. 101.12 lakhs (Consolidated).
- The single operating segment is the supply of medical equipment and related service contracts.
What happened to Aprameya Engineering's margins in Q2 FY27?
EBITDA for the quarter: Rs. 216.21 lakhs, up 97% year-on-year (YoY).
Locked: what Aprameya Engineering Ltd said on margins
Also locked on this page: capex, fundraising, order book
Free account, 30 seconds. No card needed.
What capex is Aprameya Engineering planning?
See what Aprameya Engineering Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Healthcare Equipment & Supplies
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Aprameya Engineering raising money or cutting debt?
The Consolidated Statement of Cash Flow (Page 10) shows proceeds from long-term borrowings of Rs. 15.00…
Locked: what Aprameya Engineering Ltd said on fundraising
Also locked on this page: margins, capex, order book
Free account, 30 seconds. No card needed.
How big is Aprameya Engineering's order book?
See what Aprameya Engineering Ltd said on order book & pipeline — free account, 30 seconds.
More Q2 FY27 results in Healthcare Equipment & Supplies
- Molbio Diagnosti Q2 FY27 results
- Poly Medicure Q2 FY27 results
- Sahajanand Medi Q2 FY27 results
- Fischer Medical Q2 FY27 results
- Tarsons Products Q2 FY27 results
- Laxmi Dental Q2 FY27 results
- Vasa Denticity Q2 FY27 results
- OSEL Devices Q2 FY27 results
All Q2 FY27 results | Healthcare Equipment & Supplies rankings
Continue your research
What Aprameya Enginee's management said in earlier quarters
Others in Healthcare Equipment & Supplies this season
- Fischer Medical (Q2 FY27)
For the quarter ended September 30, 2026, the Standalone revenue from operations was ₹27.62 Lakhs compared to ₹742.69 Lakhs in Q2 FY 2025, showing a…
- Mohini Health (Q2 FY27)
Revenue from operations for the half year ended 30th Sept 2026 is ₹11,043.00 lakhs, compared to ₹7,353.87 lakhs for the half year ended 30th Sept 2025, showing…
- QMS Medical (Q2 FY27)
4,470.00 lakhs in Q2 2025), a year-on-year increase of approximately 17.5% . Key results statement takeaways from QMS Medical Allied Services Ltd's Q2 FY27 resu
- OSEL Devices (Q2 FY27)
31.8% increase ((19,363.37 . Key results statement takeaways from OSEL Devices Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Equipment & Supplies
on management's own guidance
- Strong growth2
- Strong growth1
- Poly MedicureGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Aprameya Engineering Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Aprameya Engineering Ltd Q2 FY27 results?
Revenue from operations for the half year ended 30.09.2026 is Rs. 1,712.53 lakhs (Consolidated) and Rs. 1,673.57 lakhs (Standalone). EBITDA for the quarter: Rs. 216.21 lakhs, up 97% year-on-year (YoY).
What is Aprameya Engineering Ltd share price analysis?
Aprameya Engineering Ltd currently shows a neutral. The stock trades at a P/E of 51.7 with a market cap of ₹260 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Aprameya Engineering Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
